National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov
In English | En español
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

CDK inhibitor SCH 727965
A pyrazolo[1,5-a]pyrimidine with potential antineoplastic activity. CDK inhibitor SCH 727965 selectively inhibits cyclin dependent kinases CDK1, CDK2, CDK5, and CDK9; inhibition of CDK1 and CDK2 may result in cell cycle repression and tumor cell apoptosis. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonym:cyclin-dependent kinase inhibitor SCH 727965
Code name:SCH 727965



Previous:CD20-targeted polypeptide TRU-015, CD3/CD28 costimulated vaccine-primed autologous T-cells, CD4+CD25+ regulatory T cells, CD40 agonist monoclonal antibody CP-870,893, CDDO
Next:CDKI AT7519, Ce-Vi-Sol, CEA-Scan, CeaVac, Cecon

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov